Skip to main content

TERUMO GLOBAL

Search

Select Region

Show — Select Region Hide — Select Region

- Regions/Countries
  - - Europe
    - Latin America
      - Mexico
        
        Brazil
        
        Colombia
        
        Chile and Argentina
        
        Latin America
  - - Asia Pacific
    - Australia
    - Korea
    - Vietnam
    - China
    - India
- Global Business website

About Terumo
About Terumo
Dear Stakeholders
Terumo Group Identity
Terumo Group Code of Conduct
Corporate Profile
Corporate Governance
Compliance
Procurement Activity
Regulations and Standards
Directors and Executive Officers
History
TERUMO’s Purpose
Our Stories
Terumo's Response to COVID-19
Business Overview
Business Overview
TIS Division (Terumo Interventional Systems)
Neurovascular Division (MicroVention)
Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division
Vascular Graft Division (Terumo Aortic)
Hospital Care Solutions Division
Life Care Solutions Division
Pharmaceutical Solutions Division
Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
Sustainability
Sustainability
Sustainability News
Message from Top Management
Sustainability at the Terumo Group
Resolving Healthcare Challenges
Creating a Diverse and Inclusive Workplace
Reducing Environmental Footprint
Serving Our Communities
Report Library
GRI Standards Index
Technology
Technology
Basic Information
Basic Information Top
Research and Development
Production and Supply
Intellectual Property
Terumo Fellows
Stories - Our Technologies
Investors
Investors
Management Policy
Management Policy
Top Management Message
Business Risks
Disclaimer
IR Policy
Financial Highlights
IR Library
IR Library
Financial Statements
Presentations
Consolidated Financial Statements
Terumo Reports
IR Events
Shareholders & Stock
Shareholders Meeting
Stock Information
Shareholder Return
Credit Ratings and Corporate Bond
Analyst Coverage
Articles of Incorporation
Site Quote
IR Inquiries
News
News
October 04, 2022
Financial
Notification Regarding Status of Acquisition of the Company's Own Shares (PDF 104.44 KB)
(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation)
October 03, 2022
Corporate
Terumo Aortic Announces New Technology Add-on Payment for Thoraflex Hybrid Device in the United States
September 29, 2022
Corporate
MicroVention Celebrates 25 Years in Neuroendovascular Technologies that Improve Patient Lives
Global Network
Global Network
Japan
North America
South America
Europe, Middle East and Africa
Greater China
Asia and Pacific

Breadcrumb

Home
News

News

Move to top

Top

Refining Searches

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

Corporate

Financial

December 07, 2018

Corporate

Terumo Announces European Launch of Biosimilar Using Terumo's PLAJEX™ Pre-fillable Syringes
November 14, 2018

Corporate

Terumo Cardiovascular Group Announces 510(k) Clearance for the CDI® Blood Parameter Monitoring System 550, Adding New Parameter for Oxygen Delivery

Monitoring oxygen delivery helps reduce the incidence of Acute Kidney Injury during cardiac surgery
November 14, 2018

Corporate

Terumo Announces GMP Certification Has Been Awarded for the Manufacturing and Filling of Premixed Intravenous Solutions from the FDA (U.S.A.)
October 15, 2018

Corporate

Grant Offered to Impact Patients and Communities Managing Sickle Cell Disease
October 09, 2018

Corporate

UniCAR Therapy and Terumo BCT Collaborate to Advance CAR T-Cell Therapies and Create a Shanghai, China Center of Excellence
September 19, 2018

Corporate

Terumo to Launch the Ultimaster Tansei Drug Eluting Stent in Japan
August 29, 2018

Financial

Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 71.51 KB)
August 16, 2018

Corporate

President and CEO of Terumo BCT David Perez to Retire after FY 2018; Antoinette Gawin Named as Successor
August 08, 2018

Financial

Terumo Revises the First-Half and Full-Year Results Forecast for FY2018 (PDF 210.41 KB)
August 08, 2018

Financial

Notice Concerning the Issuance of Stock Options (Share Warrants) (PDF 156.72 KB)
August 06, 2018

Corporate

Terumo's Affiliate in China to Receive an Approval for PD solution
July 31, 2018

Corporate

Terumo Announces Receiving European Medicines Agency GMP Certification for the Manufacturing and Filling of Biologics in PLAJEX™ Polymer Pre-fillable Syringes at Yamaguchi Subsidiary's Plant
July 24, 2018

Corporate

Terumo Acquires China-based Essen Technology To Enter Drug-eluting Stent Market in China
July 18, 2018

Corporate

U.S. FDA Approves Terumo BCT's Sodium Citrate 4% w/v Anticoagulant Solution Amid Shortage
July 09, 2018

Corporate

Terumo to Increase Production Capacity for Alliance Business Pre-filled Syringes Capital Investment of 7 Billion Yen in Terumo Yamaguchi D&D Corporation
July 05, 2018

Corporate

Terumo Enters an Exclusive Distribution Relationship for Japan with Piramal Critical Care for Fentanyl Injection, a Prescription-only Narcotic Analgesic for Postoperative Pain Management
July 04, 2018

Corporate

Terumo Announces Shipping Delays for Products from Ashitaka Factory
June 22, 2018

Corporate

Terumo Announces Voting Results for the Election of Directors (PDF 199.06 KB)
June 20, 2018

Corporate

Terumo Acquires CE Marking for Kanshas Drug Coated Balloon Catheter for Lower Extremities
June 19, 2018

Corporate

New data demonstrate clinical experience with LifePearl microspheres in over 300 hepatocellular carcinoma patients
June 12, 2018

Corporate

MicroVention Announces FDA Clearance for Thrombectomy Device

SOFIA® Catheter; A New Device for the Revascularization of Patients with Acute Ischemic Stroke
May 31, 2018

Corporate

MicroVention® Announces FDA Approval for Neuro Stent Device

The LVIS® and LVIS® Jr. stents are the first stents PMA approved for stent-assisted coil embolization
May 24, 2018

Corporate

Terumo to Launch the Ultimaster Tansei Drug Eluting Stent in Europe
May 11, 2018

Corporate

Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow
May 09, 2018

Financial

Terumo Revises Upward Dividends for the Fiscal Year Ended March 31, 2018 (PDF 205 KB)
May 09, 2018

Corporate

Terumo Appoints the Candidates for Directors (PDF 197.37 KB)
May 07, 2018

Corporate

Terumo to Distribute Dexcom's Continuous Glucose Monitoring Systems in Japan
April 30, 2018

Corporate

First U.S. Clinical Trial Evaluating Red Blood Cells Derived From Pathogen-Reduced Whole Blood Begins
April 30, 2018

Corporate

Terumo Aortic Announces the First Implants of the Relay®Branch Thoracic Stent-Graft System Early Feasibility Study
April 25, 2018

Corporate

Terumo Acquires CE Marking for Ultimaster Tansei Drug Eluting Stent Available in Europe Starting in May
April 24, 2018

Corporate

Terumo Aortic Announces European Launch of Relay®Pro Thoracic Stent Graft System at Charing Cross 2018
April 23, 2018

Corporate

Vascutek and Bolton Medical Merge as 'Terumo Aortic'

- New company brings together two leaders in the aortic implant market
- New identity underlines global growth ambitions further to $43m factory investment
- Merger unites two world-class innovators focused on expanding aortic treatment options
April 12, 2018

Corporate

Terumo and Quirem Welcome the Positive Reimbursement Decision for QuiremSpheres® in the Netherlands
March 02, 2018

Corporate

Terumo Acquires Large Bore Vascular Closure Device to Expand Its Interventional Access Device Business in the Fast Growing Segment
February 26, 2018

Corporate

Terumo Pharmaceutical Solutions wins Asia-Pacific Industry Award
February 24, 2018

Corporate

New Collaboration with StafaCT Will Optimize Patient Pathways for Cellular Treatments
February 13, 2018

Corporate

Terumo Announces £33m Investment in Scottish Medical Device Factory
February 08, 2018

Financial

Terumo Revises the Full-Year Results Forecast for FY2017 (PDF 205.85 KB)
January 29, 2018

Corporate

Terumo Integrates Two R&D Facilities in Silicon Valley to Accelerate Development of Innovative Medical Devices
January 25, 2018

Corporate

Terumo Announces Change of Directors and Executive Officers (PDF 198.89 KB)
January 19, 2018

Corporate

Approval of LifePearl® Microspheres as a Class III device in Europe

Pagination

Previous page
Current page1
Next page

Footer Menu

Show — Footer Menu Hide — Footer Menu

- Investors
- News
  - - News
    - Press Inquiries
- Global Network

About Terumo
Business Overview
Sustainability
Technology
Investors
News
Global Network

Footer

Show — Footer Hide — Footer

Terms and Conditions of Use
Privacy Policy
Cookie Policy
Cookie Settings
Social Media Policy
Site Map

Copyright © 2022 Terumo Corporation, All Rights Reserved.